$GILD Up to date company activities and other impo
Post# of 5326
Posted On: 12/09/2013 2:19:34 PM
$GILD Up to date company activities and other important information about $GILD
$GILD
DD Notes ~ http://www.ddnotesmaker.com/GILD
##### recent news/filings ~ source: finance.yahoo.com
Mon, 09 Dec 2013 19:14:47 GMT ~ 3:09 am Gilead Sciences announces interim Phase 2 results for GS-9973 in previously treated chronic lymphocytic leukemia
- 3:09 am Gilead Sciences announces interim Phase 2 results for GS-9973 in previously treated chronic lymphocytic leukemia
read full: http://finance.yahoo.com/news/inplay-briefing....html#gild
*********************************************************
Mon, 09 Dec 2013 18:50:00 GMT ~ A 2013 Top Ten Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co., Covering the Biotechnology Sector: Opportunities in Hepatitis C and Genomic Technologies
- 67 WALL STREET, New York - December 9, 2013 - The Wall Street Transcript has just published its Top Ten Equity Analyst Interviews of 2013 Report. This special feature contains expert industry commentary ...
read full: http://finance.yahoo.com/news/2013-top-ten-wa...00342.html
*********************************************************
Mon, 09 Dec 2013 16:30:00 GMT ~ Gilead's Hep-C Approval No Surprise, Stock Gains Anyway
- Go, go Gilead (GILD)! Shares of the biotech company are on the move today after Gilead's hepatitis-C drug, to be sold under the brand name Sovaldi, was approved by the FDA. JPMorgan's Geoff Meacham and team weren't surprised by the announcement: Overall, we are not surprised by the FDA's decision given the recent AdCom panel's unanimous favorable recommendation...Up next is data from the ION studies with the fixed dose combination (FDA) of Sovaldi + ledipasvir expected to read out shortly, which we expect to support a supplementary regulatory filing in 2Q14. Morgan Stanley's David Risinger and team wonder if the Gilead's high price for Sovaldi could cause problems: Currently payers (including the government) do not spend much on the majority of hepatitis C patients.
read full: http://blogs.barrons.com/stockstowatchtoday/2...p;ru=yahoo
*********************************************************
Mon, 09 Dec 2013 16:24:00 GMT ~ Celgene, Infinity Rise On Blood Cancer Drug Data
- Celgene, Infinity Rise On Blood Cancer Drug Data
read full: http://news.investors.com/120913-682196-celge...;ven=yahoo
*********************************************************
Mon, 09 Dec 2013 16:12:41 GMT ~ Gilead Sciences: A Unique Stallion
- Taking down Gilead ( GILD ) seems to be beyond the reach authors of tales intended to frighten investors into selling this outstanding stock. The attempts have been repetitive but short of success. Gilead ...
read full: http://seekingalpha.com/article/1886051-gilea...urce=yahoo
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=GILD&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=GILD&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/GILD/company-info
Ticker: $GILD
OTC Market Place: Not Available
CIK code: 0000882095
Company name: Gilead Sciences, Inc.
Company website: http://www.gilead.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/GILD/filings
Latest financials: http://www.otcmarkets.com/stock/GILD/financials
Latest news: http://www.otcmarkets.com/stock/GILD/news - http://finance.yahoo.com/q/h?s=GILD+Headlines
Major holdings: http://data.cnbc.com/quotes/GILD/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=GILD+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/GILD.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=GILD
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Gilead+Sciences%2C...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ces%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.gilead.com
Alexa: http://www.alexa.com/siteinfo/http://www.gilead.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.gilead.com
http://www.pennystocktweets.com/stocks/profile/GILD
##### last known share structure ~ source: otcmarkets.com
Market Value: $105,034,413,761 a/o Dec 06, 2013
Shares Outstanding: 1,533,349,106 a/o Oct 18, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/GILD
$GILD
DD Notes ~ http://www.ddnotesmaker.com/GILD
##### recent news/filings ~ source: finance.yahoo.com
Mon, 09 Dec 2013 19:14:47 GMT ~ 3:09 am Gilead Sciences announces interim Phase 2 results for GS-9973 in previously treated chronic lymphocytic leukemia
- 3:09 am Gilead Sciences announces interim Phase 2 results for GS-9973 in previously treated chronic lymphocytic leukemia
read full: http://finance.yahoo.com/news/inplay-briefing....html#gild
*********************************************************
Mon, 09 Dec 2013 18:50:00 GMT ~ A 2013 Top Ten Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co., Covering the Biotechnology Sector: Opportunities in Hepatitis C and Genomic Technologies
- 67 WALL STREET, New York - December 9, 2013 - The Wall Street Transcript has just published its Top Ten Equity Analyst Interviews of 2013 Report. This special feature contains expert industry commentary ...
read full: http://finance.yahoo.com/news/2013-top-ten-wa...00342.html
*********************************************************
Mon, 09 Dec 2013 16:30:00 GMT ~ Gilead's Hep-C Approval No Surprise, Stock Gains Anyway
- Go, go Gilead (GILD)! Shares of the biotech company are on the move today after Gilead's hepatitis-C drug, to be sold under the brand name Sovaldi, was approved by the FDA. JPMorgan's Geoff Meacham and team weren't surprised by the announcement: Overall, we are not surprised by the FDA's decision given the recent AdCom panel's unanimous favorable recommendation...Up next is data from the ION studies with the fixed dose combination (FDA) of Sovaldi + ledipasvir expected to read out shortly, which we expect to support a supplementary regulatory filing in 2Q14. Morgan Stanley's David Risinger and team wonder if the Gilead's high price for Sovaldi could cause problems: Currently payers (including the government) do not spend much on the majority of hepatitis C patients.
read full: http://blogs.barrons.com/stockstowatchtoday/2...p;ru=yahoo
*********************************************************
Mon, 09 Dec 2013 16:24:00 GMT ~ Celgene, Infinity Rise On Blood Cancer Drug Data
- Celgene, Infinity Rise On Blood Cancer Drug Data
read full: http://news.investors.com/120913-682196-celge...;ven=yahoo
*********************************************************
Mon, 09 Dec 2013 16:12:41 GMT ~ Gilead Sciences: A Unique Stallion
- Taking down Gilead ( GILD ) seems to be beyond the reach authors of tales intended to frighten investors into selling this outstanding stock. The attempts have been repetitive but short of success. Gilead ...
read full: http://seekingalpha.com/article/1886051-gilea...urce=yahoo
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=GILD&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=GILD&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/GILD/company-info
Ticker: $GILD
OTC Market Place: Not Available
CIK code: 0000882095
Company name: Gilead Sciences, Inc.
Company website: http://www.gilead.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/GILD/filings
Latest financials: http://www.otcmarkets.com/stock/GILD/financials
Latest news: http://www.otcmarkets.com/stock/GILD/news - http://finance.yahoo.com/q/h?s=GILD+Headlines
Major holdings: http://data.cnbc.com/quotes/GILD/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=GILD+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/GILD.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=GILD
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Gilead+Sciences%2C...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ces%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.gilead.com
Alexa: http://www.alexa.com/siteinfo/http://www.gilead.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.gilead.com
http://www.pennystocktweets.com/stocks/profile/GILD
##### last known share structure ~ source: otcmarkets.com
Market Value: $105,034,413,761 a/o Dec 06, 2013
Shares Outstanding: 1,533,349,106 a/o Oct 18, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/GILD
(0)
(0)